Nasasinuspray Sine Conservans (Xylometazoline Hydrochloride)

Xylometazoline, the active ingredient in Nasasinuspray Sine Conservans, is an imidazoline nasal decongestant presented as a nasal spray for intranasal use. It works by reducing swelling of the nasal mucosa and provides rapid relief of congestion caused by the common cold, sinusitis, and allergic rhinitis in both adults and children.

GNH USA supplies Nasasinuspray Sine Conservans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for importers.

Xylometazoline is an imidazoline nasal decongestant that reduces swelling of nasal passages.

- Common cold: alleviates nasal blockage and improves airflow during acute viral upper‑respiratory infections. - Sinusitis: decreases mucosal edema to facilitate sinus drainage and relieve pressure. - Allergic rhinitis: reduces nasal obstruction caused by allergen‑induced inflammation.

Xylometazoline nasal spray may cause local and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation in the nostrils. - Sneezing: transient increase in sneezing episodes after application. - Dry nose: dryness or crusting of the nasal mucosa. - Taste disturbance: altered taste sensation following use. - Nasal bleeding: occasional epistaxis, especially with aggressive spraying. - Headache: mild headache that resolves without intervention.

Serious or Rare Side Effects: - Rebound congestion: worsening nasal blockage after prolonged use beyond recommended duration. - Hypertension: elevated blood pressure in susceptible individuals, particularly with overuse. - Cardiac arrhythmia: irregular heart rhythm that may require medical attention. - Severe nasal ulceration: rare ulcerative lesions of the nasal mucosa.

When using Xylometazoline nasal spray, consider the following precautions to minimize risks.

- Limit duration: use no longer than three consecutive days to avoid rebound congestion. - Underlying conditions: avoid if you have uncontrolled hypertension or severe heart disease. - Pregnancy: consult a healthcare professional before use; safety not established. - Pediatric use: follow age‑specific recommendations; not for infants under 6 months. - Drug interactions: do not combine with other nasal decongestants or MAO inhibitors without advice. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): concurrent use may increase risk of hypertensive crisis. - Other topical nasal decongestants: combined vasoconstriction can cause severe hypertension or rebound congestion.

Moderate Interactions (Monitor Closely): - Systemic sympathomimetics (e.g., pseudoephedrine): may enhance cardiovascular effects. - Antihypertensive medications: may reduce efficacy of blood pressure control. - Antidepressants affecting norepinephrine: monitor blood pressure for potential elevation.